SNAP Message Board - Msg: 14755136

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNAP

SNAP 7.800

+2.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (99)	11/8/2000 11:53:53 AM
From: Mike McFarland	Read Replies (1) of 124

Synaptic Pharmaceutical Announces Discovery of New Class of Receptors synapticcorp.com Synaptic Pharmaceutical Presents Findings on G Protein-Coupled Receptors at Neuroscience Meeting Synaptic Pharmaceutical Trademarks Its Universal Functional Assay (Snap UFA(TM)) for Identifying Drug Targets Synaptic Pharmaceutical Discovery Points to Possible New Pathway for Treating Depression Synaptic Pharmaceutical Grants Licenses to The R.W. Johnson Pharmaceutical Research Institute Synaptic Pharmaceutical Makes Available Its Universal Functional Assay (UFA) For Identifying Drug Targets Synaptic Pharmaceutical to Refocus Business Strategy Towards Near-Term Revenue

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next